iRadimed
IRMD
60 hedge funds and large institutions have $48.2M invested in iRadimed in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 15 closing their positions.
69% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 16
9% less funds holding
Funds holding: 66 → 60 (-6)
10% less capital invested
Capital invested by funds: $53.7M → $48.2M (-$5.59M)
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
+$654K |
| 2 |
SIM
Spark Investment Management
New York
|
+$630K |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$540K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$515K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$413K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
Castleark Management
Chicago,
Illinois
|
-$4.3M |
| 2 |
AR
Advisory Research
Chicago,
Illinois
|
-$1.41M |
| 3 |
TCM
Tygh Capital Management
Portland,
Oregon
|
-$1.32M |
| 4 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
-$1.32M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$925K |
IRMD Hedge Fund Activity: Q2 2016 in Review
60 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2016, worth a combined $48.2M — down 10% from $53.7M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of IRMD and 10 opened new positions — a net loss of 5 holders — while 16 trimmed existing stakes and 27 added.
The largest buyer was Ativo Capital Management, adding an estimated $654K. The largest seller was Castleark Management, exiting entirely with an estimated $4.3M sold.
- 60 institutional investors held iRadimed (IRMD) as of Q2 2016, down from 66 in Q1 2016.
- Funds reported $48.2M of iRadimed stock for Q2 2016, down 10% quarter-over-quarter.
- 10 funds opened new iRadimed positions in Q2 2016 and 15 closed out, a net change of -5 holders.
- The largest iRadimed buyer in Q2 2016 was Ativo Capital Management, an estimated $654K added.
- The largest iRadimed seller in Q2 2016 was Castleark Management, an estimated $4.3M sold.
Based on aggregated 13F filings for Q2 2016.